JPMorgan Chase & Co.
04/27/2026 | Press release | Distributed by Public on 04/27/2026 14:25
Supplemental Prospectus (Form 424B3)
April 27, 2026 Registration Statement Nos. 333-293684 and 333-293684-01; Rule 424(b)(3)
Amendment no. 1 to pricing supplement dated April 20, 2026 to transition product supplement no. 4-I dated April 17, 2026, underlying supplement no. 1-I
dated April 17, 2026 and the prospectus and prospectus supplement, each dated April 17, 2026
JPMorgan Chase Financial Company LLC
Structured Investments
Callable Contingent Interest Notes Linked to the Least
Performing of the Russell 2000
®
Index, the Dow Jones
Industrial Average
®
and the S&P 500
®
Index due April 24, 2031
Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.
Notwithstanding anything to the contrary set forth in the pricing supplement dated April 20, 2026, related to the notes referred to above
(the "pricing supplement"), the Fees and Commissions and the Proceeds to Issuer are as set forth below:
Price to Public (1) Fees and Commissions (2) Proceeds to Issuer
Per note $1,000 $3.50 $996.50
Total $1,000,000 $3,500 $996,500
(1) See "Supplemental Use of Proceeds" in the pricing supplement for information about the components of the price to public of the notes.
(2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of
$3.50 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See "Plan of Distribution (Conflicts of
Interest)" in the accompanying product supplement.
CUSIP: 46660TAS9
Investing in the notes involves a number of risks. See "Risk Factors" beginning on page S-2 of the accompanying
prospectus supplement, "Risk Factors" beginning on page PS-11 of the accompanying product supplement and "Selected
Risk Considerations" beginning on page PS-6 of the pricing supplement.
Neither the Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the
notes or passed upon the accuracy or the adequacy of this amendment, the pricing supplement or the accompanying product
supplement, underlying supplement, prospectus supplement and prospectus. Any representation to the contrary is a criminal offense.
The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and
are not obligations of, or guaranteed by, a bank.
You should read this amendment together with the pricing supplement and the related product supplement, underlying supplement,
prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see "Additional Terms
Specific to the Notes" in the pricing supplement.
• Pricing supplement dated April 20, 2026:
• Transition product supplement no. 4-I dated April 17, 2026:
• Underlying supplement no. 1-I dated April 17, 2026:
• Prospectus supplement and prospectus, each dated April 17, 2026:
JPMorgan Chase & Co. published this content on April 27, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 27, 2026 at 20:29 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]